# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-24-000071
Filing Date
2024-08-07
Accepted
2024-08-07 16:30:54
Documents
83
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgnd-20240630.htm iXBRL | 10-Q | 1337509
2 | EX-2.1 | exhibit21apeironbiologicsa.htm | EX-2.1 | 543348
3 | EX-10.1 | exhibit101_ligand-firstame.htm | EX-10.1 | 86293
4 | EX-10.2 | exhibit102_ligand-agenusxp.htm | EX-10.2 | 713342
5 | EX-31.1 | lgnd_63024exhibit311.htm | EX-31.1 | 15159
6 | EX-31.2 | lgnd_63024exhibit312.htm | EX-31.2 | 15429
7 | EX-32.1 | lgnd_63024exhibit321.htm | EX-32.1 | 11158
13 |  | image_0a.jpg | GRAPHIC | 117
14 |  | image_2a.jpg | GRAPHIC | 90146
15 |  | image_6a.jpg | GRAPHIC | 2642
16 |  | lgnd-20240630_g1.jpg | GRAPHIC | 43732
| Complete submission text file | 0000886163-24-000071.txt |  | 10488144

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20240630.xsd | EX-101.SCH | 63651
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20240630_cal.xml | EX-101.CAL | 101827
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20240630_def.xml | EX-101.DEF | 385134
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20240630_lab.xml | EX-101.LAB | 846651
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20240630_pre.xml | EX-101.PRE | 611133
85 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20240630_htm.xml | XML | 1194291

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 241184326
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)